semaglutide ndc Minnesota doctor says FDA weight-loss drug cutoff is 'devastating' for patients NDC Code 0169-4136-11 - Semaglutide

Description

Renal outcomes in the EXenatide study of cardiovascular event lowering (EXSCEL) Diabetes

Michael HennessyUBS Wealth ManagementAtlantaGeorgia - Atlanta (High Net Worth)$1M$1.4B$2-10M$1-5MStacy LewisCreative PlanningAtlantaGeorgia - Atlanta (High Net Worth)$5M$649M$2-50M$1-20MNate GibbsMorgan Stanley Wealth ManagementAtlantaGeorgia - Atlanta (High Net Worth)$1M$3B$1-18M$750K-5MJosh KrentzmanMerrill Wealth ManagementAtlantaGeorgia - Atlanta (High Net Worth)$1M$792M$10-20M$2-10MEdward KatzKatz Wealth Management Group | Buckhead Financial Advisors | Wells Fargo Advisors Financial NetworkAtlantaGeorgia - Atlanta (High Net Worth)$700K$467M$1-30M$500K-20MJohn PattersonOnePoint BFG Wealth PartnersAtlantaGeorgia - Atlanta (High Net Worth)$1M$758M$2-10M$1-8MCasey JonesRBC Wealth ManagementAtlantaGeorgia - Atlanta (High Net Worth)$3M$2.5B$3-25M$30MJason MossTruist Investment ServicesAtlantaGeorgia - Atlanta (High Net Worth)$2M$496M$3-30M$2-100MProfile SpotlightVarun MarneniCPC Advisors | Raymond JamesAtlantaGeorgia - Atlanta (High Net Worth)$10M$1.4B$10-100M$5-100MJeff SchultzJanney Montgomery ScottAtlantaGeorgia - Atlanta (High Net Worth)$3M$312M$3-20M$2-10MMary Ellen GarrettMerrill Wealth ManagementAtlantaGeorgia - Atlanta (High Net Worth)$500K$1.2B$500K-15M$2-8MDaniel KaufmanMorgan Stanley Wealth ManagementAtlantaGeorgia - Atlanta (High Net Worth)$500K$1.5B$2.5-15M$1-10MHoward Joe IIIMerrill Wealth ManagementAtlantaGeorgia - Atlanta (High Net Worth)$0$441M$2-35M$1-25MTripp RawlsUBS Wealth ManagementAtlantaGeorgia - Atlanta (High Net Worth)$1M$362M$2-10M$750K-3MLisa M

A new semaglutide drug specifically targeted for weight loss is hitting the Australian market next week for the first time, with manufacturer Novo Nordisk to launch Wegovy on 5 August